Filing Details

Accession Number:
0001140361-13-036922
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-09-24 18:24:05
Reporting Period:
2013-09-20
Filing Date:
2013-09-24
Accepted Time:
2013-09-24 18:24:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
315545 Provectus Pharmaceuticals Inc PVCT Pharmaceutical Preparations (2834) 900031917
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1550814 Jan Koe 1204 E. Central Road
Suite 100
Arlington Heights IL 60005
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-09-20 100,000 $0.00 586,300 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Warrants (right to buy) Acquisiton 2013-09-20 150,000 $0.00 150,000 $1.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
150,000 2013-09-20 2018-09-20 No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 150,000 Indirect By Vekoe Partners LLC
Footnotes
  1. The reported securities were purchased together, such that the purchase price for each share of common stock together with a warrant to purchase one and one-half shares of common stock is $0.75.
  2. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.